Show simple item record

dc.contributor.advisorBingham, Jennifer
dc.contributor.authorBenson, Cody
dc.contributor.authorLee, Heather
dc.contributor.authorMichael, Rianne
dc.date.accessioned2019-11-25T17:17:11Z
dc.date.available2019-11-25T17:17:11Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/10150/636241
dc.descriptionClass of 2019 Abstract, Poster, and Paperen_US
dc.description.abstractSpecific Aims: Evaluate the impact of targeted psychotropic medication adherence interventions by pharmacists on psychotropic medication adherence rates in patients with type 2 diabetes and determine whether patient-specific variables, such as age, gender, or type of psychotropic medication being taken, influence the degree of impact. Methods: Adherence, as indicated by proportion of days covered (PDC), was measured before and after face-to-face counseling by a community pharmacist. Pharmacists were alerted to counsel patients receiving Medicare Part D prescription coverage who were prescribed a psychotropic medication and exhibited a PDC of <85%. Data regarding PDC, age, gender, and type of psychotropic medication were analyzed for patients between 18 and 84 years of age with type 2 diabetes. Main Results: The data set contained 8,167 patients eligible for analysis, including 5,438 women (mean age=63.6 years, SD=11.5) and 2,729 men (mean age=61.6 years, SD=10.3). There was significant improvement in PDC after pharmacist intervention overall (mean PDC increase=13.5%, SD=20.2, p<0.01) and for each subgroup, with the exception of nefazodone (n=3, p=0.66). Patients 65 years and older showed the greatest improvement (PDC change=14.5, p<0.01), followed by patients aged 40-64 years (PDC change=12.5, p<0.01) and then 20-39 years (PDC change=9.1, p<0.01). Conclusions: Targeted face-to-face interventions by pharmacists significantly improved psychotropic medication adherence in adult patients with type 2 diabetes receiving Medicare Part D prescription coverage. Improvement was seen regardless of gender, age, or type of psychotropic medication, except nefazodone, and was greater with increasing age. The degree of improvement also varied among certain psychotropic medications.en_US
dc.language.isoen_USen_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author.en_US
dc.subjectDiabetesen_US
dc.subjectMental Health Medicationen_US
dc.subjectPsychotropic Medicationen_US
dc.subjectType 2 Diabetesen_US
dc.subjectPortion of days covereden_US
dc.subjectMedicare Part Den_US
dc.subject.meshMental Healthen_US
dc.subject.meshPsychotropic Drugsen_US
dc.subject.meshDiabetes Mellitus, Type 2en_US
dc.subject.meshMedication Adherenceen_US
dc.titleInvestigating the Impact of a Mental Health Adherence Intervention on Mental Health Medication Adherence in Patients with Diabetesen_US
dc.typetexten_US
dc.typeElectronic Reporten_US
dc.contributor.departmentCollege of Pharmacy, The University of Arizonaen_US
dc.description.collectioninformationThis item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.en_US
refterms.dateFOA2019-11-25T17:17:11Z


Files in this item

Thumbnail
Name:
Group 9 Final Project Poster.pdf
Size:
1.815Mb
Format:
PDF
Thumbnail
Name:
Group 9 Final Project Report_JMB ...
Size:
262.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record